Chien-Wei Peng
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 18, 2024
Higher end-of-treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg-negative chronic hepatitis B patients stopping antivirals.Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Peng
|Aug 25, 2023
Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis.Wen-Juei Jeng, Rong-Nan Chien, Yi-Cheng Chen
|Jul 23, 2022
A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study.Chien-Wei Peng, Wen-Juei Jeng, Hwai-I Yang
|Oct 07, 2021
Highly significant differences in HBsAg kinetics among patients with two types of hepatitis B flare, with and without retreatment.Wen-Juei Jeng, Yen-Chun Liu, Chien-Wei Peng
|Dec 04, 2020
The impact of hepatitis flare on HBeAg loss was effective mainly in the first year of Nucleot(s)ide therapy in chronic hepatitis B.Chien-Wei Peng, Wen-Juei Jeng, Rong-Nan Chien
Pageof 1
